Prevalence of prostate cancer in the Seventh Region of Chile

被引:0
|
作者
Baechler, R [1 ]
Henríquez, R [1 ]
Aqueveque, X [1 ]
Martínez, ME [1 ]
Soto, A [1 ]
机构
[1] Hosp Reg Talca, Serv Salud Maule, Dept Programas Personas, Talca, Chile
关键词
carcinoma in situ; prostate - specific antigen; prostatic neoplasms;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In 1998, there were 1,218 deaths in Chile caused by prostate cancer. This figure results in a death rate of 16.6 per 100,000 males for this disease. Aim: To assess the prevalence of prostate cancer in the Seventh Region of Chile. Material and methods: A probabilistic sample of 327 males aged 40 to 59 years old was studied. In all, a codified questionnaire was applied, a digital rectal examination was performed and a blood sample was drawn to measure prostate specific antigen. All digital rectal examinations were performed by the same observer. Patients with an abnormal rectal examination or prostate specific antigen were subjected to a prostatic biopsy under ultrasound guidance. Results: In 14 subjects, the digital rectal examination was considered abnormal and in seven, prostate specific antigen was over 4 ng/ml. All subjects with elevated prostate specific antigen had an abnormal rectal examination. In three of the 14 subjects, the biopsy showed a well differentiated adenocarcinoma. All three were aged over 50 years old. The resulting calculated prevalence of prostate cancer was 9.2 per 1,000 males (CI 4.2-14.1). Conclusions: the cost effectiveness of screening for early diagnosis of prostate cancer must be calculated, to decide its incorporation in preventive medical examinations (Rev Med Chile 2001; 129: 1305-10).
引用
收藏
页码:1305 / 1310
页数:6
相关论文
共 50 条
  • [21] Impact of prostate volume on the active surveillance in prostate cancer
    Beaujouan, Florent
    Bertherat, Walter
    Hammoudi, Zakaria
    Chicaud, Marie
    Descazeaud, Aurelien
    JOURNAL OF CLINICAL UROLOGY, 2024,
  • [22] Racial differences in prostate-specific antigen-based prostate cancer screening: State-by-state and region-by-region analyses
    Jindal, Tarun
    Kachroo, Naveen
    Sammon, Jesse
    Dalela, Deepansh
    Sood, Akshay
    Vetterlein, Malte W.
    Karabon, Patrick
    Jeong, Wooju
    Menon, Mani
    Trinh, Quoc-Dien
    Abdollah, Firas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (07)
  • [23] Prostate cancer detection at low prostate specific antigen
    Schröder, FH
    van der Cruijsen-Koeter, I
    de Koning, HJ
    Vis, AN
    Hoedemaeker, RF
    Kranse, R
    JOURNAL OF UROLOGY, 2000, 163 (03) : 806 - 811
  • [24] Prostate specific antigen only progression of prostate cancer
    Moul, JW
    JOURNAL OF UROLOGY, 2000, 163 (06) : 1632 - 1642
  • [25] Undetectable prostate specific antigen in disseminated prostate cancer
    Beardo, P
    Fernández, PL
    Corral, JM
    Filella, X
    Alcover, J
    JOURNAL OF UROLOGY, 2001, 166 (03) : 993 - 993
  • [26] Prostate specific antigen kinetics in the management of prostate cancer
    Sengupta, Shomik
    Amling, Christopher
    D'Amico, Anthony V.
    Blute, Michael L.
    JOURNAL OF UROLOGY, 2008, 179 (03) : 821 - 826
  • [27] PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening
    Kearns, James T.
    Holt, Sarah K.
    Wright, Jonathan L.
    Lin, Daniel W.
    Lange, Paul H.
    Gore, John L.
    CANCER, 2018, 124 (13) : 2733 - 2739
  • [28] Prevalence and risk factors for incidental prostate cancer in patients after transurethral resection of the prostate with negative results on prostate biopsy: A retrospective study
    Guo, Zhenlang
    He, Junwei
    Pan, Jun
    Huang, Lijuan
    Cao, Jiadong
    Bai, Zunguang
    Wang, Shusheng
    Xiang, Songtao
    Gu, Chiming
    Wang, Zhaohui
    INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (02) : 201 - 206
  • [29] Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies
    Bishop, F. L.
    Rea, A.
    Lewith, H.
    Chan, Y. K.
    Saville, J.
    Prescott, P.
    von Elm, E.
    Lewith, G. T.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2011, 14 (01) : 1 - 13
  • [30] Prevalence of Prostate Cancer Risk Factors and Symptoms in Indigenous People in Tabasco, Mexico
    Sanchez Sanchez, Kristell
    Cruz Sanchez, Marcelina
    Rivas Acuna, Valentina
    Perez Chan, Manuel
    REVISTA CUIDARTE, 2021, 12 (02)